Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients
Type 2 Diabetes Mellitus
Enrolment: 50 · Results not recorded
Biologic
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Type 2 Diabetes Mellitus
Enrolment: 50 · Results not recorded
Cerebrovascular Disorders
Enrolment: 5 · Results not recorded
Anti Aging
Enrolment: 20 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Lethal whole-body irradiation with an Alphee medical accelerator; dose ranging at 15, 13, 12 and 10 Gy, with 10 Gy used for all therapy experiments, producing acute radiation syndrome with gastrointestinal injury
Extracellular vesicles, but not MSC, significantly delayed death after 10 Gy irradiation (log-rank p < 0.0001), reducing the instantaneous risk of death by 85% (hazard ratio 0.15) and delaying LD50 by 3.5 days. They prevented the radiation-induced rise in gut permeability (5.7 +/- 1.0 versus 9.1 +/…
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.